| Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 |
|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | |||||||||
Net income | |||||||||
192,676 | 531,413 | 715,394 | 487,664 | 538,125 | 410,423 | 0 | -55 | -570 | -413 |
Adjustments to reconcile net income to net cash used in operating activities: | |||||||||
Income earned on investment held in Trust Account | |||||||||
616,268 | 820,302 | 920,810 | 877,142 | - | - | - | - | - | 0 |
Changes in operating assets and liabilities: | |||||||||
Prepaid expenses and other current assets | |||||||||
14,656 | 43,926 | -17,215 | -17,215 | - | - | - | - | - | - |
Prepaid expenses | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Accounts payable and accrued expenses | |||||||||
54,225 | 1 | -16,143 | 6,411 | - | - | - | - | - | 413 |
Franchise tax payable | |||||||||
20,144 | 19,945 | 6,489 | -33,026 | - | - | - | - | - | 0 |
Income tax payable | |||||||||
0 | -20,628 | -462,985 | 177,312 | - | - | - | - | - | 0 |
Net cash used in operating activities | |||||||||
-363,879 | -333,497 | -660,840 | -221,566 | -92,767 | -144,663 | 0 | -55 | -983 | 0 |
Cash flow from investing activities | |||||||||
Cash deposited in Trust Account | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Net cash provided by (used in) investing activities | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Cash flows from financing activities | |||||||||
Proceeds from sale of shares of common stock to initial stockholder | |||||||||
- | - | - | - | - | - | - | - | 0 | 12,500 |
Proceeds from note payable- related party | |||||||||
- | - | - | - | - | - | - | 35,000 | 30,000 | 0 |
Repayment of note payable- related party | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Payment of offering costs associated with initial public offering | |||||||||
- | - | - | - | - | - | - | 10,707 | 37,972 | 0 |
Proceeds from sale of private units | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Net cash provided by financing activities | |||||||||
- | - | - | - | 0 | 150,137,213 | -19,085 | 24,293 | -7,972 | 12,500 |
Net increase (decrease) in cash | |||||||||
-215,725 | -89,343 | 205,950 | -221,566 | -92,767 | 492,550 | -19,085 | 24,238 | -8,955 | 12,500 |
Supplemental disclosure of non-cash financing activities: | |||||||||
Initial classification of common stock subject to possible redemption | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Deferred underwriting commissions charged to additional paid-in-capital in connection with the initial public offering | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Offering costs paid by initial stockholder in exchange for common stock | |||||||||
- | - | - | - | - | - | - | - | 0 | 12,500 |
Accrued formation and offering costs | |||||||||
- | - | - | - | - | - | - | 413 | - | - |
Change in value of common stock subject to possible redemption | |||||||||
192,676 | 531,413 | 715,394 | 487,664 | - | - | - | - | - | - |